Moreover, our findings suggest that restoration of C/EBPδ activity could hold therapeutic value in pancreatic ductal adenocarcinoma, although the latter claim needs to be substantiated in future studies. The gene discussed is CEBPD; the disease is pancreatic ductal adenocarcinoma.